Insights On Upstream Manufacturing

  1. An Extended Kinetics Study Of AAV Viral Vector Production 5/28/2025

    This study aims to explore the kinetics of capsid formation and impurity profiles over time, offering insights that can inform future process improvements.

  2. Taking A Look At AAV Production Using HEK293 In A Perfusion Process 5/28/2025

    Discover a scalable, cost-effective solution for gene therapy manufacturing with VintaProcess™ — featuring VintaCell™, VintaFect™, and fixed-bed bioreactor technology.

  3. The Evolution Of AAV Production: Scaling Through Nature Instead Of Brute Force 5/28/2025

    This study evaluates the performance and productivity of VintaProcess in addressing the persistent manufacturing challenges in AAV gene therapy production.

  4. Cell Therapy Bioprocessing Workflow Cinematic 5/28/2025

    Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.

  5. Animal-Origin Free Peptones In Cell Culture Media For Viral Vaccine Manufacturing 5/27/2025

    Investigate the impact of peptone supplementation on adenovirus and VSV production, highlighting its potential to reduce serum dependency in cell culture media. 

  6. Innovations In Mycoplasma And Sterility Testing For Biopharma 5/22/2025

    In this webinar, our expert speakers will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.

  7. Maximizing Media Strategies: Expert Insights On Boosting Performance 5/22/2025

    Optimize biopharma media strategies for consistent protein quality. Experts discuss formats, variability, and actionable analytics in this on-demand virtual roundtable.

  8. Exploring MSC-EV Attributes – Analytical Comparison Of Tissue Sources And Production Platforms 5/22/2025

    Uncover how analytical tools assess the impact of production process choices and tissue sources on the quality of cell-derived extracellular vesicles (EVs).

  9. Overcoming The Challenges Of Product Concentration Monitoring At A CDMO 5/22/2025

    See how simplified, in-line analytics are changing the way CDMOs manage product concentration in fed-batch and perfusion processes.

  10. Tackling Allogeneic Immunotherapy's Scale-Up Bottleneck With Vertical-Wheel® Bioreactors 5/21/2025

    New bioreactor technology provides an optimal environment for shear-sensitive cells, addressing key scale-up challenges for allogeneic therapies from research to commercial production.